SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-099152
Filing Date
2024-04-17
Accepted
2024-04-17 16:39:04
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d799386ds3.htm S-3 194760
2 EX-5.1 d799386dex51.htm EX-5.1 10190
3 EX-23.1 d799386dex231.htm EX-23.1 1572
4 EX-FILING FEES d799386dexfilingfees.htm EX-FILING FEES 31800
5 GRAPHIC g799386g0416133646737.jpg GRAPHIC 2091
6 GRAPHIC g799386g50c34.jpg GRAPHIC 56261
  Complete submission text file 0001193125-24-099152.txt   319998
Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Filer) CIK: 0001781174 (see all company filings)

IRS No.: 825125532 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278761 | Film No.: 24851612
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)